Mammalian models for the study of H7 virus pathogenesis and transmission

Current Topics in Microbiology and Immunology

Volumn 385, Issue , 2014, Pages 275-305

  Belser, Jessica A ^a   Tumpey, Terrence M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; MONOCLONAL ANTIBODY; OSELTAMIVIR;

ANTIBODY RESPONSE; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CHICKEN; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; FERRET; HUMAN; IMMUNOGENICITY; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H7; INFLUENZA VIRUS A H7N1; INFLUENZA VIRUS A H7N2; INFLUENZA VIRUS A H7N3; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H7N9; NONHUMAN; RECEPTOR BINDING; UNITED STATES; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; CLASSIFICATION; DISEASE MODEL; GENETICS; INFLUENZA; MAMMAL; MOUSE; PATHOGENICITY; PHYSIOLOGY; TRANSMISSION; VIROLOGY; VIRULENCE;

AVIAN INFLUENZA VIRUS; MAMMALIA; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MAMMALS; MICE; VIRULENCE;

EID: 84921697006     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2014_383     Document Type: Article

References (154)

1. (2007) Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill 12(5): E070532.1
2. Aamir UB, Naeem K, Ahmed Z, Obert CA, Franks J, Krauss S, Seiler P, Webster RG (2009) Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from Pakistan. Virology 390:212–220
3. Abbas MA, Spackman E, Swayne DE, Ahmed Z, Sarmento L, Siddique N, Naeem K, Hameed A, Rehmani S (2010) Sequence and phylogenetic analysis of H7N3 avian influenza viruses isolated from poultry in Pakistan 1995-2004. Virol J 7:137
4. Abd El-Rahim IH, Hussein M (2004) An epizootic of equine influenza in Upper Egypt in 2000. Rev Sci Tech 23:921–930
5. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S et al (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358:261–273
6. Alexander DJ (2007) Summary of avian influenza activity in Europe, Asia, Africa, and Australasia, 2002–2006. Avian Dis 51:161–166
7. Arzey GG, Kirkland PD, Arzey KE, Frost M, Maywood P, Conaty S, Hurt AC, Deng YM, Iannello P, Barr I et al (2012) Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis 18:814–816
8. Bahgat MM, Blazejewska P, Schughart K (2011) Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection. Virol J 8:27
9. Banks J, Plowright L (2003) Additional glycosylation at the receptor binding site of the hemagglutinin (HA) for H5 and H7 viruses may be an adaptation to poultry hosts, but does it influence pathogenicity? Avian Dis 47:942–950
10. Banks J, Speidel E, Alexander DJ (1998) Characterisation of an avian influenza A virus isolated from a human—is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch Virol 143:781–787
11. Baranovich T, Burnham AJ, Marathe BM, Armstrong J, Guan Y, Shu Y, Peiris JM, Webby RJ, Webster RG, Govorkova EA (2013) The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J Infect Dis
12. Belser JA, Blixt O, Chen LM, Pappas C, Maines TR, Van Hoeven N, Donis R, Busch J, McBride R, Paulson JC et al (2008) Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc Natl Acad Sci USA 105:7558–7563
13. Belser JA, Bridges CB, Katz JM, Tumpey TM (2009a) Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis 15:859–865
14. Belser JA, Davis CT, Balish A, Edwards LE, Zeng H, Maines TR, Gustin KM, Martinez IL, Fasce R, Cox NJ et al (2013a) Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. J Virol 87:5746–5754
15. Belser JA, Gustin KM, Maines TR, Pantin-Jackwood MJ, Katz JM, Tumpey TM (2012a) Influenza virus respiratory infection and transmission following ocular inoculation in ferrets. PLoS Pathog 8:e1002569
16. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J et al (2013b) Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556–559
17. Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Katz JM, Tumpey TM (2007) Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: Enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 81:11139–11147
18. Belser JA, Maines TR, Gustin KM, Katz JM, Tumpey TM (2013c) Kinetics of viral replication and induction of host responses in ferrets differs between ocular and intranasal routes of inoculation. Virology 438:56–60
19. Belser JA, Sleeman K, Pearce MB, Katz JM, Gubareva LV, Tumpey TM (2012b) Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route. Antimicrob Agents Chemother 56:1616–1618
20. Belser JA, Szretter KJ, Katz JM, Tumpey TM (2009b) Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv Virus Res 73:55–97
21. Belser JA, Tumpey TM (2013) H5N1 pathogenesis studies in mammalian models. Virus Res
22. Belser JA, Wadford DA, Xu J, Katz JM, Tumpey TM (2009c) Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract. J Virol 83:7075–7084
23. Berhane Y, Hisanaga T, Kehler H, Neufeld J, Manning L, Argue C, Handel K, Hooper-McGrevy K, Jonas M, Robinson J et al (2009) Highly pathogenic avian influenza virus A (H7N3) in domestic poultry, Saskatchewan, Canada, 2007. Emerg Infect Dis 15:1492–1495
24. Brown IH (2010) Summary of avian influenza activity in Europe, Asia, and Africa, 2006–2009. Avian Dis 54:187–193
25. Bulach D, Halpin R, Spiro D, Pomeroy L, Janies D, Boyle DB (2010) Molecular analysis of H7 avian influenza viruses from Australia and New Zealand: genetic diversity and relationships from 1976 to 2007. J Virol 84:9957–9966
26. CDC (2004) Update: influenza activity—United States, 2003–2004 season. MMWR Morb Mortal Wkly Rep 53:284–287
27. Christensen JP, Doherty PC, Branum KC, Riberdy JM (2000) Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J Virol 74:11690–11696
28. Cowling BJ, Jin L, Lau EH, Liao Q, Wu P, Jiang H, Tsang TK, Zheng J, Fang VJ, Chang Z et al (2013) Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: A population-based study of laboratory-confirmed cases. Lancet 382:129–137
29. Cox RJ, Major D, Hauge S, Madhun AS, Brokstad KA, Kuhne M, Smith J, Vogel FR, Zambon M, Haaheim LR et al (2009) A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. Influenza Other Respi Viruses 3:107–117
30. de Jong RM, Stockhofe-Zurwieden N, Verheij ES, de Boer-Luijtze EA, Ruiter SJ, de Leeuw OS, Cornelissen LA (2013) Rapid emergence of a virulent PB2 E627K variant during adaptation of highly pathogenic avian influenza H7N7 virus to mice. Virol J 10:276
31. de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA (2005) Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol 79:12401–12407
32. de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA (2010) Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84:1597–1606
33. Di Trani L, Porru S, Bonfanti L, Cordioli P, Cesana BM, Boni A, Di Carlo AS, Arici C, Donatelli I, Tomao P et al (2012) Serosurvey against H5 and H7 avian influenza viruses in Italian poultry workers. Avian Dis 56:1068–1071
34. Dudley JP (2008) Public health and epidemiological considerations for avian influenza risk mapping and risk assessment. Ecol Soc 13:21
35. Eames KT, Webb C, Thomas K, Smith J, Salmon R, Temple JM (2010) Assessing the role of contact tracing in a suspected H7N2 influenza a outbreak in humans in Wales. BMC Infect Dis 10:141
36. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B et al (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843–850
37. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ et al (2004) Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 101:1356–1361
38. Gabbard JD, Dlugolenski D, Van Riel D, Marshall N, Galloway SE, Howerth EW, Campbell PJ, Jones C, Johnson S, Byrd-Leotis L et al (2013) Novel H7N9 influenza virus shows low infectious dose, high growth and efficient contact transmission in the guinea pig model. J Virol
39. Gabriel G, Abram M, Keiner B, Wagner R, Klenk HD, Stech J (2007) Differential polymerase activity in avian and mammalian cells determines host range of influenza virus. J Virol 81:9601–9604
40. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J (2005) The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci USA 102:18590–18595
41. Gabriel G, Klingel K, Planz O, Bier K, Herwig A, Sauter M, Klenk HD (2009) Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus. Am J Pathol 175:1178–1186
42. Gabriel G, Nordmann A, Stein DA, Iversen PL, Klenk HD (2008) Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. J Gen Virol 89:939–948
43. Gambaryan AS, Matrosovich TY, Philipp J, Munster VJ, Fouchier RA, Cattoli G, Capua I, Krauss SL, Webster RG, Banks J et al (2012) Receptor-binding profiles of H7 subtype influenza viruses in different host species. J Virol 86:4370–4379
44. Gambaryan AS, Tuzikov AB, Pazynina GV, Desheva JA, Bovin NV, Matrosovich MN, Klimov AI (2008) 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol J 5:85
45. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ et al (2013a) Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 368:2277–2285
46. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K et al (2013b) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888–1897
47. Garcia-Sastre A (2001) Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375–384
48. Gerloff NA, Jones J, Simpson N, Balish A, Elbadry MA, Baghat V, Rusev I, de Mattos CC, de Mattos CA, Zonkle LE et al (2013) A high diversity of eurasian lineage low pathogenicity avian influenza A viruses circulate among wild birds sampled in Egypt. PLoS One 8:e68522
49. Goff PH, Krammer F, Hai R, Seibert CW, Margine I, Garcia-Sastre A, Palese P (2013) Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol 87:8235–8240
50. Gonzalez-Reiche AS, Morales-Betoulle ME, Alvarez D, Betoulle JL, Muller ML, Sosa SM, Perez DR (2012) Influenza a viruses from wild birds in Guatemala belong to the North American lineage. PLoS One 7:e32873
51. Haasbach E, Reiling SJ, Ehrhardt C, Droebner K, Ruckle A, Hrincius ER, Leban J, Strobl S, Vitt D, Ludwig S et al (2013) The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. Antiviral Res 99:336–344
52. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solorzano A, Garcia-Sastre A, Palese P et al (2013) Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun 4:2854
53. Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840–1842
54. He F, Kumar SR, Syed Khader SM, Tan Y, Prabakaran M, Kwang J (2013) Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus. Antiviral Res 100:207–214
55. Hirst M, Astell CR, Griffith M, Coughlin SM, Moksa M, Zeng T, Smailus DE, Holt RA, Jones S, Marra MA et al (2004) Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis 10:2192–2195
56. Horimoto T, Kawaoka Y (1994) Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol 68:3120–3128
57. Horimoto T, Kawaoka Y (2001) Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 14:129–149
58. Hovden AO, Brokstad KA, Major D, Wood J, Haaheim LR, Cox RJ (2009) A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice. Influenza Other Respi Viruses 3:21–28
59. Ilyushina NA, Govorkova EA, Russell CJ, Hoffmann E, Webster RG (2007) Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 88:1266–1274
60. Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y (2008) Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 26:1742–1750
61. Jones YL, Swayne DE (2004) Comparative pathobiology of low and high pathogenicity H7N3 Chilean avian influenza viruses in chickens. Avian Dis 48:119–128
62. Jonges M, Bataille A, Enserink R, Meijer A, Fouchier RA, Stegeman A, Koch G, Koopmans M (2011) Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak. J Virol 85:10598–10604
63. Joseph T, McAuliffe J, Lu B, Jin H, Kemble G, Subbarao K (2007) Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J Virol 81:10558–10566
64. Joseph T, McAuliffe J, Lu B, Vogel L, Swayne D, Jin H, Kemble G, Subbarao K (2008) A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology 378:123–132
65. Kaminski MM, Ohnemus A, Cornitescu M, Staeheli P (2012) Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virus. J Gen Virol 93:555–559
66. Kapczynski DR, Pantin-Jackwood M, Guzman SG, Ricardez Y, Spackman E, Bertran K, Suarez DL, Swayne DE (2013) Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection. J Virol 87:9086–9096
67. Kawaoka Y (1991) Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model. J Virol 65:3891–3894
68. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P (2007) Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 88:1403–1409
69. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P (2007) Protective role of beta interferon in host defense against influenza A virus. J Virol 81:2025–2030
70. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A et al (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587–593
71. Krammer F, Cox RJ (2013) The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines. Expert Rev Vaccines 12:1369–1372
72. Krammer F, Margine I, Hai R, Flood A, Hirsh A, Tsvetnitsky V, Chen D, Palese P (2013) H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J Virol
73. Kreijtz JH, Kroeze EJ, Stittelaar KJ, de Waal L, van Amerongen G, van Trierum S, van Run P, Bestebroer T, Kuiken T, Fouchier RA, et al (2013) Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies. Vaccine
74. Kurtz J, Manvell RJ, Banks J (1996) Avian influenza virus isolated from a woman with conjunctivitis. Lancet 348:901–902
75. Lam WY, Yeung AC, Chan PK (2011) Apoptosis, cytokine and chemokine induction by nonstructural 1 (NS1) proteins encoded by different influenza subtypes. Virol J 8:554
76. Lang G, Gagnon A, Geraci JR (1981) Isolation of an influenza A virus from seals. Arch Virol 68:189–195
77. Lee CW, Lee YJ, Senne DA, Suarez DL (2006) Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics. Virology 353:388–395
78. Legastelois I, Garcia-Sastre A, Palese P, Tumpey TM, Maines TR, Katz JM, Vogel FR, Moste C (2007) Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respi Viruses 1:95–104
79. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Xiang N, Chen E, Tang F, Wang D, et al (2013) Preliminary report: epidemiology of the avian influenza a (H7N9) outbreak in China. N Engl J Med
80. Li Y, Li C, Liu L, Wang H, Wang C, Tian G, Webster RG, Yu K, Chen H (2006) Characterization of an avian influenza virus of subtype H7N2 isolated from chickens in northern China. Virus Genes 33:117–122
81. Lopez-Martinez I, Balish A, Barrera-Badillo G, Jones J, Nunez-Garcia TE, Jang Y, Aparicio-Antonio R, Azziz-Baumgartner E, Belser JA, Ramirez-Gonzalez JE, et al (2013) Highly pathogenic avian influenza A(H7N3) virus in poultry workers, Mexico, 2012. Emerg Infect Dis 19
82. Lv H, Han J, Zhang P, Lu Y, Wen D, Cai J, Liu S, Sun J, Yu Z, Zhang H, et al (2013) Mild illness in avian influenza A(H7N9) virus-infected poultry worker, Huzhou, China, April 2013. Emerg Infect Dis 19
83. Maines TR, Chen LM, Matsuoka Y, Chen H, Rowe T, Ortin J, Falcon A, Nguyen TH, le Mai Q, Sedyaningsih ER et al (2006) Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A 103:12121–12126
84. Maines TR, Chen LM, Van Hoeven N, Tumpey TM, Blixt O, Belser JA, Gustin KM, Pearce MB, Pappas C, Stevens J et al (2011) Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 413:139–147
85. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH et al (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484–487
86. Maines TR, Lu XH, Erb SM, Edwards L, Guarner J, Greer PW, Nguyen DC, Szretter KJ, Chen LM, Thawatsupha P et al (2005) Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 79:11788–11800
87. Mancini DA, Mendonca RM, Pereira AS, Kawamoto AH, Vannucchi CI, Pinto JR, Mori E, Mancini Filho J (2012) Influenza viruses in adult dogs raised in rural and urban areas in the state of Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 54:311–314
88. Manz B, Gotz V, Wunderlich K, Eisel J, Kirchmair J, Stech J, Stech O, Chase G, Frank R, Schwemmle M (2011) Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus. J Biol Chem 286:8414–8424
89. Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, Garcia-Sastre A et al (2013) Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses. J Virol 87:10435–10446
90. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y (2000) Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74:8502–8512
91. Maurer-Stroh S, Lee RT, Gunalan V, Eisenhaber F (2013) The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA. Virol J 10:139
92. Max V, Herrera J, Moreira R, Rojas H (2007) Avian influenza in Chile: a successful experience. Avian Dis 51:363–365
93. Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K (2010) A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol 84:11950–11960
94. Mok CK, Lee HH, Chan MC, Sia SF, Lestra M, Nicholls JM, Zhu H, Guan Y, Peiris JM (2013) Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio 4
95. Mok CK, Lee HH, Lestra M, Nicholls JM, Chan CW, Sia SF, Zhu H, Poon LL, Guan Y, Peiris JM (2014) Amino-acid substitutions in polymerase basic protein 2 gene contributes to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol
96. Morgan O, Kuhne M, Nair P, Verlander NQ, Preece R, McDougal M, Zambon M, Reacher M (2009) Personal protective equipment and risk for avian influenza (H7N3). Emerg Infect Dis 15:59–62
97. Munster VJ, de Wit E, van Riel D, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Kuiken T, Fouchier RA (2007) The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 196:258–265
98. Myers KP, Setterquist SF, Capuano AW, Gray GC (2007) Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 45:4–9
99. Nacken W, Ehrhardt C, Ludwig S (2012) Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Biol Chem 393:525–534
100. Nguyen-Van-Tam JS, Nair P, Acheson P, Baker A, Barker M, Bracebridge S, Croft J, Ellis J, Gelletlie R, Gent N et al (2006) Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill 11(E060504):2
101. Ostrowsky B, Huang A, Terry W, Anton D, Brunagel B, Traynor L, Abid S, Johnson G, Kacica M, Katz J et al (2012) Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003. Emerg Infect Dis 18:1128–1131
102. Pappas C, Matsuoka Y, Swayne DE, Donis RO (2007) Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol 14:1425–1432
103. Pasick J, Berhane Y, Hisanaga T, Kehler H, Hooper-McGrevy K, Handel K, Neufeld J, Argue C, Leighton F (2010) Diagnostic test results and pathology associated with the 2007 Canadian H7N3 highly pathogenic avian influenza outbreak. Avian Dis 54:213–219
104. Pasick J, Handel K, Robinson J, Copps J, Ridd D, Hills K, Kehler H, Cottam-Birt C, Neufeld J, Berhane Y et al (2005) Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J Gen Virol 86:727–731
105. Pasick J, Pedersen J, Hernandez MS (2012) Avian influenza in North America, 2009-2011. Avian Dis 56:845–848
106. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF (1999) Human infection with influenza H9N2. Lancet 354:916–917
107. Perez-Ramirez E, Gerrikagoitia X, Barral M, Hofle U (2010) Detection of low pathogenic avian influenza viruses in wild birds in Castilla-La Mancha (south central Spain). Vet Microbiol 146:200–208
108. ProMED-mail (2013) Avian Influenza (90): ITALY (EMILIA-ROMAGNA) Poultry, HPAI H7N7, Human, Public health. ProMED mail
109. Puzelli S, Di Trani L, Fabiani C, Campitelli L, De Marco MA, Capua I, Aguilera JF, Zambon M, Donatelli I (2005) Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J Infect Dis 192:1318–1322
110. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, Ji H, Huang Y, Cai PQ, Lu B et al (2013) Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 347:f4752
111. Rajesh Kumar S, Syed Khader SM, Kiener TK, Szyporta M, Kwang J (2013) Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus. PLoS One 8:e63856
112. Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, van Boheemen S, de Meulder D, Lexmond P, Linster M, Herfst S et al (2013) Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501:560–563
113. Rigoni M, Shinya K, Toffan A, Milani A, Bettini F, Kawaoka Y, Cattoli G, Capua I (2007) Pneumo- and neurotropism of avian origin Italian highly pathogenic avian influenza H7N1 isolates in experimentally infected mice. Virology 364:28–35
114. Rigoni M, Toffan A, Viale E, Mancin M, Cilloni F, Bertoli E, Salomoni A, Marciano S, Milani A, Zecchin B et al (2010) The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian influenza (HPAI) viruses in mammals. Vet Res 41:66
115. Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, Hulse-Post DJ, Humberd J, Trichet M, Rehg JE, Webby RJ et al (2006) The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med 203:689–697
116. Scheiblauer H, Kendal AP, Rott R (1995) Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol 140:341–348
117. Senne DA (2007) Avian influenza in North and South America, 2002–2005. Avian Dis 51:167–173
118. Senne DA (2010) Avian influenza in North and South America, the Caribbean, and Australia, 2006–2008. Avian Dis 54:179–186
119. Senne DA, Panigrahy B, Kawaoka Y, Pearson JE, Suss J, Lipkind M, Kida H, Webster RG (1996) Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis 40:425–437
120. Senne DA, Suarez DL, Pedersen JC, Panigrahy B (2003) Molecular and biological characteristics of H5 and H7 avian influenza viruses in live-bird markets of the northeastern United States, 1994–2001. Avian Dis 47:898–904
121. Shinya K, Suto A, Kawakami M, Sakamoto H, Umemura T, Kawaoka Y, Kasai N, Ito T (2005) Neurovirulence of H7N7 influenza A virus: brain stem encephalitis accompanied with aspiration pneumonia in mice. Arch Virol 150:1653–1660
122. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y (2007) Adaptation of an H7N7 equine influenza A virus in mice. J Gen Virol 88:547–553
123. Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV (2013) R292K substitution and drug susceptibility of influenza A(H7N9) viruses. Emerg Infect Dis 19:1521–1524
124. Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF III, Glenn GM (2013) Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/ 2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Vaccine 31:4305–4313
125. Song H, Wan H, Araya Y, Perez DR (2009) Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol J 6:126
126. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, Mauel S, Gruber AD, Schughart K (2009) Host genetic background strongly influences the response to influenza a virus infections. PLoS One 4:e4857
127. Suarez DL, Senne DA, Banks J, Brown IH, Essen SC, Lee CW, Manvell RJ, Mathieu-Benson C, Moreno V, Pedersen JC et al (2004) Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 10:693–699
128. Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67:1761–1764
129. Suguitan AL Jr, Matsuoka Y, Lau YF, Santos CP, Vogel L, Cheng LI, Orandle M, Subbarao K (2012) The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/ 1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J Virol 86:2706–2714
130. Szecsi J, Boson B, Johnsson P, Dupeyrot-Lacas P, Matrosovich M, Klenk HD, Klatzmann D, Volchkov V, Cosset FL (2006) Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses. Virol J 3:70
131. Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR et al (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:3744–3753
132. Tharakaraman K, Jayaraman A, Raman R, Viswanathan K, Stebbins NW, Johnson D, Shriver Z, Sasisekharan V, Sasisekharan R (2013) Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell 153:1486–1493
133. Timoney PJ (1996) Equine influenza. Comp Immunol Microbiol Infect Dis 19:205–211
134. Tretyakova I, Pearce MB, Florese R, Tumpey TM, Pushko P (2013) Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses. Virology 442:67–73
135. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, Haller O, Garcia-Sastre A, Staeheli P (2007) The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81:10818–10821
136. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R et al (2004) Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 10:2196–2199
137. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y et al (2013) Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551–555
138. Webster RG (1993) Are equine 1 influenza viruses still present in horses? Equine Vet J 25:537–538
139. Webster RG, Geraci J, Petursson G, Skirnisson K (1981) Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med 304:911
140. Whiteley A, Major D, Legastelois I, Campitelli L, Donatelli I, Thompson CI, Zambon MC, Wood JM, Barclay WS (2007) Generation of candidate human influenza vaccine strains in cell culture—rehearsing the European response to an H7N1 pandemic threat. Influenza Other Respi Viruses 1:157–166
141. WHO (2013) Avian influenza A (H10N8)
142. Xiong X, Martin SR, Haire LF, Wharton SA, Daniels RS, Bennett MS, McCauley JW, Collins PJ, Walker PA, Skehel JJ et al (2013) Receptor binding by an H7N9 influenza virus from humans. Nature 499:496–499
143. Xu L, Bao L, Deng W, Dong L, Zhu H, Chen T, Lv Q, Li F, Yuan J, Xiang Z, et al (2013a) Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. J Infect Dis
144. Xu L, Bao L, Deng W, Zhu H, Chen T, Lv Q, Li F, Yuan J, Xiang Z, Gao K et al (2013b) The mouse and ferret models for studying the novel avian-origin human influenza A (H7N9) virus. Virol J 10:253
145. Xu Q, Chen Z, Cheng X, Xu L, Jin H (2013c) Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus. PLoS One 8:e76884
146. Yamayoshi S, Yamada S, Fukuyama S, Murakami S, Zhao D, Uraki R, Watanabe T, Tomita Y, Macken C, Neumann G, et al (2013) Virulence-Affecting Amino Acid Changes in the PA Protein of H7N9 Influenza A Viruses. J Virol
147. Yang H, Carney PJ, Donis RO, Stevens J (2012) Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus. J Virol 86:8645–8652
148. Yang H, Chen LM, Carney PJ, Donis RO, Stevens J (2010) Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog 6:e1001081
149. Yuan J, Zhang L, Kan X, Jiang L, Yang J, Guo Z, Ren Q (2013) Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan. Clin Infect Dis 57:1367–1368
150. Zhang H, Li X, Guo J, Li L, Chang C, Li Y, Bian C, Xu K, Chen H, Sun B (2014) The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. J Gen Virol
151. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J et al (2013) H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341:410–414
152. Zhong W, Liu F, Dong L, Lu X, Hancock K, Reinherz EL, Katz JM, Sambhara S (2010) Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated crossprotection against influenza A virus infections. PLoS One 5:e10583
153. Zhou B, Zhong N, Guan Y (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357:1450–1451
154. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D et al (2013) Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341:183–186